Association between immune-related adverse events and recurrence dynamics under adjuvant anti–PD-1 therapy in resected melanoma

IntroductionAdjuvant anti–PD-1 therapy has significantly improved recurrence-free survival (RFS) in patients with resected high-risk melanoma, yet a substantial proportion still relapse. Identifying predictors of recurrence remains a clinical priority.MethodsWe retrospectively analyzed 84 patients w...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Gökhan Şahin, Caner Acar, Haydar Çağatay Yüksel, Salih Tünbekici, Pınar Açar, Banu Yaman, Burçak Karaca
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2025-11-01
Seria:	Frontiers in Oncology
Hasła przedmiotowe:	melanoma immune-related adverse events anti–PD-1 therapy recurrence-free survival adjuvant immunotherapy cutaneous irAEs
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1671315/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!